Metabolic consequences of gonadotropin-releasing hormone agonists versus orchiectomy: A randomized clinical study
Read MoreIs anti-androgen monotherapy just as good as ADT with LHRH agonists in terms of overall survival?
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study.
Read MoreADT and Risk of Bone Fractures: What You Should Know
Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures—a study from the fractures and fall injuries in the elderly cohort (FRAILCO)
Read MoreIs there any difference between Lupron and Zoladex?
Effect of hormonal therapy for volume reduction, lower urinary tract symptom relief and voiding symptoms in prostate cancer: leuprolide vs goserelin.
Read MoreWhat is the optimal duration of ADT in men with high-risk prostate cancer, and what factors should be considered?
The Long and Short of It: New Lessons on the Optimal Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer and Where We Need to Go From Here
Read MoreHow likely is ADT to cause anemia?
Mechanisms Responsible for Reduced Erythropoiesis during Androgen Deprivation Therapy in Men with Prostate Cancer
Read MoreHow might ADT affect relationships with intimate partners, and what factors may help to preserve relational intimacy?
Mood, sexuality, and relational intimacy after starting androgen deprivation therapy: implications for couples
Read MoreWhat are the potential cellular mechanisms underlying effects of combination therapy with androgen deprivation?
Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier.
Read MoreWhat prevents men from meeting the minimum recommended levels of physical activity?
Physical activity and associations with treatment-induced adverse effects among prostate cancer patients
Read MoreWhat are the potential side-effects associated with long-term use of ADT?
Risks of Major Long-term Side Effects Associated with Androgen Deprivation Therapy in Men with Prostate Cancer.
Read More